Home / Doxorubicin / Belgium
BE ATC L01DB01 · updated 2 Nov 2026
Doxorubicin shortage in Belgium
Is there a Doxorubicin shortage in Belgium?
Yes. As of 2 Nov 2026, 2 Doxorubicin products are reported short in Belgium, the first since 19 Aug 2026. The company estimate for the return is 9 Nov 2026 (latest 30 Nov 2026). Main reason: manufacturing problem.
Also short in Canada, Germany, Italy, Ireland, Austria, Czechia, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 10 ml | Baxter Holding | 19 Aug 2026 | 9 Nov 2026 | Manufacturing problem Delay in the release of the end product |
| BE | Doxorubicin Accord Healthcare 2 mg/ml inf. sol. (conc.) i.v. vial 100 ml | Accord Healthcare | 14 Oct 2026 | 30 Nov 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.